[144] Snowflake Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Snowflake Inc. (SNOW) indicates a proposed sale of 25,000 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $5,866,000 and an approximate sale date of 10/02/2025. The filing shows the shares were recorded as acquired via an option granted on 12/11/2019 and lists 338,800,000 shares outstanding for the issuer. Recent activity by the same person identified in the filing, Benoit Dageville, shows multiple open-market sales over the past three months totaling 153,862 common shares. The form includes standard representations about lack of undisclosed material information and trading-plan references but contains no signature date or additional explanatory remarks in the provided content.

Positive

• Disclosure filed under Rule 144, providing required transaction details for the proposed sale
• Seller's acquisition method (option grant dated 12/11/2019) is documented in the filing

Negative

• Insider sales totaling 153,862 shares were reported in the past three months, indicating significant insider liquidity
• Provided excerpt lacks a dated signature or an explicit 10b5‑1 plan adoption date, limiting confirmation of whether trades were preplanned

Insights

Financial Analyst

TL;DR: Routine insider sale notice; modest quantity relative to outstanding shares.

The filing is a standard Rule 144 notice describing a proposed sale of 25,000 SNOW common shares valued at $5,866,000, to be executed through Fidelity on 10/02/2025. The seller previously disposed of 153,862 shares across several dates in the prior three months, producing multi‑million dollar gross proceeds. On an absolute basis these transactions generated substantial cash for the seller, but the proposed 25,000‑share sale represents a very small fraction of the reported 338,800,000 shares outstanding, indicating limited direct dilution or market supply impact based solely on the amounts disclosed here. The document lacks additional context such as a signed date or trading plan adoption date in the supplied text.

Corporate Governance Expert

TL;DR: Compliance filing appears complete on transaction details but lacks some signature metadata in the excerpt.

The submission provides the required Rule 144 transaction details: class, broker, share counts, acquisition method (option granted 12/11/2019) and sales history for the prior three months. This supports transparency around insider liquidity. However, the provided content does not display a dated signature or explicit date of any 10b5‑1 trading plan adoption, which are often included when relied upon. Absent that element in the excerpt, one cannot confirm whether sales were pursuant to a preplanned trading arrangement or executed opportunistically.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	25000	5866000.00	338800000	10/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/02/2025	Option Granted - 12/11/2019	Issuer			25000	10/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benoit Dageville Suite 3A 106 East Babcock Street Bozeman MT 59715	Common	07/10/2025	25000	5545750.00
Benoit Dageville Suite 3A 106 East Babcock Street Bozeman MT 59715	Common	07/24/2025	25000	5365812.50
Benoit Dageville Suite 3A 106 East Babcock Street Bozeman MT 59715	Common	08/07/2025	25000	5375000.00
Benoit Dageville Suite 3A 106 East Babcock Street Bozeman MT 59715	Common	08/21/2025	18750	3615187.50
Benoit Dageville Suite 3A 106 East Babcock Street Bozeman MT 59715	Common	08/28/2025	6250	1375687.50
Benoit Dageville Suite 3A 106 East Babcock Street Bozeman MT 59715	Common	09/04/2025	25000	5573000.00
Benoit Dageville Suite 3A 106 East Babcock Street Bozeman MT 59715	Common	09/09/2025	1081	241992.66
Benoit Dageville Suite 3A 106 East Babcock Street Bozeman MT 59715	Common	09/16/2025	1912	423010.88
Benoit Dageville Suite 3A 106 East Babcock Street Bozeman MT 59715	Common	09/18/2025	25000	5484000.00
Benoit Dageville Suite 3A 106 East Babcock Street Bozeman MT 59715	Common	09/23/2025	869	200287.12

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Snowflake (SNOW) disclose?

The form discloses a proposed sale of 25,000 common shares via Fidelity on the NYSE with an aggregate market value of $5,866,000 and shows 338,800,000 shares outstanding.

Who appears to be the seller in the Form 144 filing for SNOW?

The sales history listed in the filing names Benoit Dageville as the seller for multiple transactions in the prior three months.

How many shares has the seller sold in the past three months according to the filing?

The filing reports prior sales totaling 153,862 common shares over several dates in the past three months.

How were the 25,000 shares to be sold acquired according to the filing?

The filing states the shares were acquired via an option granted on 12/11/2019 and the acquisition date is recorded as 10/02/2025 in the provided table.

Does the Form 144 indicate whether the sale is part of a 10b5‑1 trading plan?

The excerpt includes a section referencing Rule 10b5‑1 but does not provide a date of plan adoption or signed confirmation in the supplied content.